BioCentury
ARTICLE | Distillery Therapeutics

Neurology

January 23, 2019 12:08 AM UTC

In vitro and mouse studies identified a quinoline-based GLO1 inhibitor that could help treat depression. In vitro screening of a library of metal-binding pharmacophores in an activity assay and optimi...

BCIQ Target Profiles

Glyoxalase I (GLO1)